Global Organ-on-a-Chip Devices Market Size Likely to Grow at a CAGR of 33.5% By 2035

The market size of the global organ-on-a-chip devices will be estimated at USD 134 million in 2025 and is expected to grow to between USD 179 million in 2026 and about USD 2409 million by 2035 with a current CAGR of 33.5% during the period of 2026 to 2035.

Organ-on-a-Chip Devices Market Revenue and Trends

Organ-on-a-chip devices are the latest and most advanced in the field of microengineering, and they completely mimic the human organ in terms of its structure and function on a very small chip-like platform. By combining live human cells with microfluidic technology, it becomes possible to recreate and control the major physiological factors, such as the flow of fluids, the pressure applied to the cells, and their interaction with each other, exactly as they occur in the human body.

The organ-on-a-chip models are very similar to real organ conditions and thus offer a more accurate study of human biology, disease mechanisms, drug efficacy, and toxicity than traditional cell cultures or animal models. The applications of these systems are mainly in the areas of drug discovery, toxicology testing, disease modeling, and research that aims to reduce animal testing while improving the reliability of preclinical studies.

What are the Factors That Have a Significant Contribution to the Growth of the Organ-on-a-Chip Devices Market?

The organ-on-a-chip devices market is predominantly propelled by the advancements in technology, which result in continuous innovations that enhance the performance, reliability, and user-friendliness of such systems. The microfluidic engineering, biomaterials, stem cell integration, and embedded biosensors have made it possible for organ-on-a-chip platforms to imitate human organ functions and microenvironments with high accuracy. Moreover, features like multi-organ connectivity, real-time monitoring, automation compatibility, and pumpless flow designs have not only improved scalability but also simplified operations. As these technologies continue to evolve, they will be a benefit to adoption, application areas, and user confidence among the pharmaceutical, biotechnology, and research sectors, hence accelerating the entire market growth.

Additionally, the increasing investment is expected to flourish the industry growth. For instance, in March 2024, the Dutch National Growth Fund decided to allocate an amount of 124.5 million euros to open up the Centre for Animal-Free Biomedical Translation, a new place for testing drugs and other medical products without using animals. Out of this total amount, 55 million euros are given unconditionally and 69.5 million euros are provided under specific conditions. The ultimate goal of this center is to produce not only safe and efficient treatments but also to minimize the use of animals for testing.

Segment Insight

By Application

The drug discovery segment is expected to grow at a significant rate over the forecast period. The expansion is a consequence of its major impact on the development of preclinical testing. OOC technology provides more lifelike models, thus improving the drug testing accuracy and predictive value. Its capacity of reproducing human organ functions in vitro makes it easier for the researchers to evaluate the drug's effectiveness, toxicity, and metabolism more accurately than using conventional methods.

Regional Insights

North America held the highest market share in 2025. The growing technological advancements in the area and presence of the major players in the area drive the market growth. Also, the favorable government initiatives flourish the industry growth.

Besides, the Asia Pacific market has the highest rate of growth in the organ-on-a-chip devices market. The increasing expenditure in healthcare infrastructure and growing prevalence of various diseases like cancer, CVD and others.

Report Scope

Recent Developments

• In February 2025, NETRI, taking advantage of its technologies' appeal to leading industrial companies, opens the first organs-on-chip factory in France and decides to settle in the Gerland biodistrict, occupying the new Bioserra 3 building with more than 1,100 m² of production labs. These production units, which were specifically designed by property developer Vaillance and specialist equipment manufacturer Dominique Dutscher to meet NETRI's requirements for cleanroom microfabrication and P2 cell culture laboratories, will allow the industrial start-up, which until now has been operating in the Lyon Biopôle Innovation Center, to boost its capacity by ten times. Ultimately, the laboratory's production capacity will allow the company to make and use 500,000 organs-on-chip devices per year. (Source: https://netri.com/netri-inaugurates-frances-first-organs-on-chip-plant-and-announces-fund-raising-of-5-m/)

List of the prominent players in the Organ-on-a-Chip Devices Market:

• SynVivo Inc.

• BICO - THE BIO CONVERGENCE COMPANY

• Valo Health

• Nortis Inc.

• AxoSim

• MIMETAS B.V.

• CN Bio Innovations Ltd

• The Charles Stark Draper Laboratory, Inc.

• Emulate Inc.

• AlveoliX AG

• Merck KGaA

• Molecular Devices LLC

• F. Hoffmann-La Roche Ltd

• Vipragen

• Axion BioSystems, Inc

• Others

The Organ-on-a-Chip Devices Market is segmented as follows:

By Product

• Liver-on-a-Chip

• Lung-on-a-Chip

• Kidney-on-a-Chip

• Intestine-on-a-Chip

• Heart-on-a-Chip

• Others

By Application

• Drug Discovery

• Toxicology Research

• Disease Modeling/Physiological Model Development

• Stem Cell Research

• Tissue Regeneration and Regenerative Medicine

By End Use

• Academic & Research Institutes

• Pharmaceutical & Biotechnology Companies

• Contract Research Organization

• Others

Regional Coverage:

North America

• U.S.

• Canada

• Mexico

• Rest of North America 

Europe

• Germany

• France

• U.K.

• Russia

• Italy

• Spain

• Netherlands

• Rest of Europe

Asia Pacific

• China

• Japan

• India

• New Zealand

• Australia

• South Korea

• Taiwan

• Rest of Asia Pacific 

The Middle East & Africa

• Saudi Arabia

• UAE

• Egypt

• Kuwait

• South Africa

• Rest of the Middle East & Africa

Latin America

• Brazil

• Argentina

• Rest of Latin America